(Q34284268)

English

Intravenous itraconazole

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Intravenous itraconazole (English)

1 reference

Europe PubMed Central

1 August 2017

author name string

D Slain

1

1 reference

Europe PubMed Central

1 August 2017

P D Rogers

2

1 reference

Europe PubMed Central

1 August 2017

J D Cleary

3

1 reference

Europe PubMed Central

1 August 2017

S W Chapman

4

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

1 August 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

1 August 2017

35

1 reference

Europe PubMed Central

1 August 2017

6

1 reference

Europe PubMed Central

1 August 2017

720-729

1 reference

Europe PubMed Central

1 August 2017

Itraconazole in Antifungal Therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

The pharmacokinetics of oral itraconazole in AIDS patients

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Itraconazole in cyclodextrin solution

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Effect of free fatty acids on liposome susceptibility to imidazole antifungals

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Endemic mycoses: a treatment update

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

In vitro studies with R 51,211 (itraconazole)

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Effect of cyclodextrin on the pharmacology of antifungal oral azoles

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Optimisation of itraconazole therapy using target drug concentrations.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Therapeutic drug monitoring of systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

High-dose itraconazole for the treatment of cerebral aspergillosis.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Lipid-based amphotericin B for the treatment of fungal infections

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1345%2FAPH.10262

21 January 2018

Identifiers

10.1345/APH.10262

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34284268&oldid=2041844076"